Improving clinical trial outcomes in amyotrophic lateral sclerosis

Individuals who are diagnosed with amyotrophic lateral sclerosis (ALS) today face the same historically intransigent problem that has existed since the initial description of the disease in the 1860s — a lack of effective therapies. In part, the development of new treatments has been hampered by an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiernan, Matthew C., Vucic, Steve, Talbot, Kevin, McDermott, Christopher J., Hardiman, Orla, Shefner, Jeremy M., Al-Chalabi, Ammar, Huynh, William, Cudkowicz, Merit, Talman, Paul, Van den Berg, Leonard H., Dharmadasa, Thanuja, Wicks, Paul, Reilly, Claire, Turner, Martin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747476/
https://www.ncbi.nlm.nih.gov/pubmed/33340024
http://dx.doi.org/10.1038/s41582-020-00434-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747476/
https://www.ncbi.nlm.nih.gov/pubmed/33340024
http://dx.doi.org/10.1038/s41582-020-00434-z

Ejemplares similares